logo-loader
viewProactive Group

Investor Update: Tekcapital’s Belluscura set to receive FDA clearance

Top stories from the Proactive Investors UK newsroom.

Tekcapital (LON:TEK) says portfolio company Belluscura is set to receive US clearance next year for its patented portable oxygen concentrator. Belluscura’s also raised £725,000 in a funding round at 15p/share.

SDX Energy (LON:SDX) has made an oil discovery at its 50% owned Rabul-7 development well in Egypt.  It encountered close to 134 feet of net heavy oil pay and flowed at around 415 barrels daily over five days.

Clinigen (LON:CLIN) has been granted UK marketing authorisations for two melatonin products to treat jet-lag. The products were previously unlicensed and Clinigen expects to sell them directly to wholesalers or through its own supply and distribution chain.

Stagecoach says it has no intention of bidding for any more rail franchises when its last licence expires in November.  The bus and train group, which has taken legal action against the government over the franchise system, posted slightly higher profits in its latest year.

We-buy-any-car owner BCA Marketplace saw underlying profits rise by 8% and the number of cars sold top one million for a second year.  BCA is in talks over a takeover by private equity firm TDR.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Tocvan preparing for a busy 2020 on a project in Mexico with...

Tocvan (CSE: TOC) Director Brodie Sutherland joined Steve Darling in the Vancouver studio of Proactive to discuss the company’s Mexican asset. Sutherland talked about the history of the project and the advantages they have because of the location.  Sutherland also told Proactive what...

9 hours, 13 minutes ago

2 min read